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Suppression of inflammation during adipogenic differentiation in human preadipocytes
Y Wang1, SC Yeung1, MSM Ip1,2, JCW Mak1,2,3
1 Department of Medicine
2 Reserach Centre of Heart, Brain, Hormone and Healthy Aging
3 Department of Pharmocology and Pharmacy
The University of Hong Kong, Hong Kong
Introduction: Preadipocytes are present in adipose tissues throughout adult life that can differentiate into 
mature adipocytes in response to environmental factors. However, little is known about the secretory 
inflammation-associated cytokines / chemokines during adipogenic differentiation.
Methods: Human preadipocytes-subcutaneous (HPA-s) cells were cultured to 80% confluence. From 
preadipocytes to mature adipocytes, a total of six induction cycles were performed. Each cycle consisted of 
two sequential procedures from differentiation medium (for 3 days) to maintenance medium (for 2 days). 
Maintenance media after each cycle were collected to determine the levels of interleukin (IL)–6, IL-8, monocyte 
chemoattractant protein 1 (MCP-1), and adiponectin using commercial ELISA kits. Oil red staining was carried 
out to assess the degree of differentiation.
Results: The levels of pro-inflammatory cytokine IL-6 and chemokine IL-8 but not MCP-1 showed a significant 
trend of reduction in maintenance medium between each cycle (P < 0.05). On the other hand, the level of anti-
inflammatory cytokine adiponectin showed a significant trend of elevation between each cycle (P < 0.05).
Conclusion: We demonstrated suppression of pro-inflammatory cytokine / chemokine and elevation of 
anti-inflammatory cytokine as the degree of differentiation increased in preadipocytes, suggesting a close 
relationship between adipogenic differentiation and inflammation.
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The effects of hyperuricaemia on endothelial-dependent and independent vascular function  
in high cardiovascular risk patients
CK Wong, Y Chen, Z Zhen, HF Tse, KH Yiu
Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
Objectives: Hyperuricaemia has been shown to be associated with adverse cardiovascular outcome particularly 
in high-cardiovascular-risk patients and could be considered as a marker for cardiovascular risk assessment. 
One of the proposed mechanisms involving hyperuricaemia is the development of vascular damage. The aim of 
this study was to examine the role of hyperuricaemia on vascular function in patients with high cardiovascular 
risk. 
Methods: We examined the relationship between hyperuricaemia and vasomotor response of the brachial 
artery by using high-resolution ultrasound in 304 subjects with established coronary artery disease and / or 
diabetes. 
Results: No significant difference was observed in flow-mediated dilatation (FMD), a marker for endothelial-
dependent vascular function, between the hyperuricaemic and normouricaemic group (3.78 ± 3.0% vs 3.88 
± 2.9%; P = 0.78). On the other hand, nitroglycerin-mediated dilatation (NMD), a marker for endothelial-
independent vascular function, was significantly lower in the hyperuricaemic group compared with the 
normouricaemic group (12.8 ± 6.9% vs 16.2 ± 7.7%; P < 0.001). Multivariate analysis demonstrated that smoking 
was the strongest predictor of FMD (b = –0.81, P = 0.02); and that smoking (b = –2.62, P = 0.003), systolic blood 
pressure (b = –0.11, P=0.001), hyperuricaemia (b = –2.11, P=0.02), and use of nitrates (b = –3.30, P=0.001) were 
independent predictors of NMD. 
Conclusion: High cardiovascular-risk patients with hyperuricaemia had a lower NMD than those with 
normouricaemia. Importantly, hyperuricaemia was independently associated with NMD after multivariable 
adjustments. To further understand the pathophysiological mechanisms involving hyperuricaemia, particularly 
in the context of impaired NMD, further experimental and clinical studies are needed. 
68
